Is anosmia an early sign of dementia onset?

Loss of Sense of Smell and Dementia Risk

Yes, loss of sense of smell (anosmia) is an early sign of dementia onset and represents a significant risk marker for future cognitive decline, particularly when severe or combined with genetic risk factors.

Evidence for Anosmia as a Dementia Predictor

The most recent and highest-quality evidence demonstrates a clear association between olfactory dysfunction and dementia risk. Anosmia is associated with approximately 2-fold increased hazard of dementia over 12 years, with severe anosmia (complete loss) showing nearly 3-fold increased risk 1. This relationship is particularly striking when combined with APOE ε4 genetic risk—carriers with anosmia face nearly 7-fold increased dementia risk, and those with two ε4 alleles show almost 20-fold increased risk 1.

The ACR Appropriateness Criteria (2022) explicitly recognizes that olfactory dysfunction is associated with neurodegenerative, cognitive, and mood disorders including Alzheimer disease and Parkinson disease 2. This guideline notes that most patients with olfactory symptoms don't require imaging unless history or physical examination warrants it, emphasizing the clinical significance of this symptom.

Mechanisms and Neuropathological Correlates

Anosmia appears to reflect actual brain neurodegeneration rather than benign aging. Research shows that impaired olfaction correlates with:

• Smaller hippocampal and entorhinal cortex volumes 3
• Higher plasma tau and neurofilament light chain concentrations (markers of neurodegeneration) 4
• Greater white matter hyperintensity volume (vascular brain injury) 4
• Faster rates of cognitive decline compared to those with normal smell 3

These findings suggest anosmia reflects underlying pathological processes affecting memory-critical brain regions, not simply isolated sensory nerve dysfunction.

Clinical Assessment Algorithm

When evaluating anosmia for dementia risk:

1. Determine severity: Distinguish between mild hyposmia versus complete anosmia—severity matters significantly for risk stratification 1

2. Assess timing and pattern: Sudden onset without nasal obstruction or rhinorrhea is more concerning than gradual decline with sinus symptoms 2

3. Consider age and demographics: Risk is highest in older adults (especially >80 years), with Black individuals showing 2-3 times higher anosmia prevalence than White individuals 5

4. Evaluate genetic risk: If available, APOE status dramatically modifies risk—ε4 carriers with anosmia warrant closer cognitive monitoring 1

5. Rule out reversible causes: Exclude acute viral infections (including COVID-19), sinonasal inflammatory disease, trauma, and medications before attributing to neurodegeneration 2

6. Perform cognitive screening: Even in the absence of subjective cognitive complaints, objective testing is warranted given the strong association with future decline 3, 4

Important Caveats

Not all anosmia predicts dementia. The 2022 guideline emphasizes that trauma, aging, upper respiratory infections, and inflammatory sinonasal disorders most commonly affect smell 2. However, when anosmia occurs without these obvious causes in older adults, particularly with sudden onset and severity, it should raise concern for underlying neurodegeneration.

The relationship between anosmia and dementia is particularly well-established for Alzheimer's disease and Parkinson's disease, where olfactory dysfunction is near-universal, early, and often severe, developing before any movement or cognitive disorder 6. Normal smell identification in suspected Parkinson's disease is rare enough that it should prompt diagnostic review 6.

Practical Implications

For older adults presenting with unexplained anosmia:

• Establish baseline cognitive function with formal testing
• Consider brain MRI if no clear reversible cause and patient has additional risk factors
• Implement closer cognitive monitoring (annually at minimum)
• Address modifiable dementia risk factors aggressively
• Counsel patients and families about increased risk without causing undue alarm

The presence of anosmia combined with subjective cognitive decline represents a particularly high-risk scenario warranting subspecialty evaluation 7, 8.